November 20, 2014 Bristol/Pfizer Clot Drug Tops Warferin in Key Study A closely-watched experimental blood thinner developed by Bristol-Myers Squibb Co and Pfizer Inc proved superior to warfarin in preventing strokes in patients with dangerously irregular heart rhythms, according to data from a pivotal late stage trial
